Profiling serum oxylipin metabolites across melanoma subtypes and immunotherapy responders
Alexander Goodman, Kylie Michel, Morgan L. MacBeth, Jaqueline Turner, Richard P. Tobin, William Allen Robinson, Kasey L. Couts
This study examines serum oxylipin profiles in melanoma subtypes and immunotherapy responders to identify potential metabolic biomarkers for treatment response.
Metabolites · Dec 23, 2025Peer-reviewedCancer Biology